|
Re: Report Of Exempt Distribution.
|
6
|
Zenith Epigenetics
|
Apr 16, 2024 07:13PM
|
|
Alpine Immune buyout by Vertex
|
7
|
Zenith Epigenetics
|
Apr 11, 2024 11:09AM
|
|
Another Canadian Biotech get bought , not Zenith yet
|
6
|
Zenith Epigenetics
|
Mar 19, 2024 12:34PM
|
|
Re: Pfizer
|
7
|
Zenith Epigenetics
|
Mar 12, 2024 04:21PM
|
|
Re: Pfizer lays out ambitious vision for cancer portfolio in bid to reinvigorate its business.
|
9
|
Zenith Epigenetics
|
Mar 02, 2024 08:33AM
|
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
7
|
Zenith Epigenetics
|
Mar 01, 2024 12:47PM
|
|
Re: Lu stepping down
|
6
|
Resverlogix Corp.
|
Feb 22, 2024 07:11PM
|
|
Re: Lu stepping down
|
5
|
Resverlogix Corp.
|
Feb 21, 2024 07:19PM
|
|
Royalty deals with Pharma
|
6
|
Resverlogix Corp.
|
Feb 08, 2024 09:22AM
|
|
Re: ZHCLF
|
4
|
Zenith Epigenetics
|
Feb 06, 2024 11:23AM
|
|
Re: ZHCLF
|
6
|
Zenith Epigenetics
|
Feb 01, 2024 10:55AM
|
|
Re: ZHCLF
|
4
|
Zenith Epigenetics
|
Jan 30, 2024 04:37PM
|
|
Epigenetics market size
|
7
|
Zenith Epigenetics
|
Jan 16, 2024 12:18PM
|
|
Pfizer seems like a good fit for a BP deal
|
4
|
Zenith Epigenetics
|
Jan 08, 2024 06:30PM
|
|
Re: Bankruptcy?
|
6
|
Resverlogix Corp.
|
Dec 20, 2023 10:20AM
|
|
Re: you won’t see anyone buying this
|
8
|
Zenith Epigenetics
|
Dec 12, 2023 08:57AM
|
|
Re: Additional Exempt Distribution
|
5
|
Zenith Epigenetics
|
Dec 06, 2023 11:28AM
|
|
Re: Additional Exempt Distribution
|
4
|
Zenith Epigenetics
|
Dec 04, 2023 09:18AM
|
|
Re: Zenith AGM
|
4
|
Zenith Epigenetics
|
Nov 22, 2023 04:23PM
|
|
Zenith AGM
|
3
|
Zenith Epigenetics
|
Nov 22, 2023 09:54AM
|
